Oxcarbazepine may be an effective option for Chinese pediatric patients with self-limited focal epilepsy of neonatal/infantile onset: a retrospective cohort study
ObjectiveThe aim of this study was to evaluate the long-term follow-up data of Chinese children with self-limited focal epilepsy with neonatal/infantile onset (SeLFE) and to investigate the clinical features, genetic background and treatment outcomes of this type of epileptic syndrome.MethodsWe cond...
Saved in:
| Main Authors: | Na Sun, Xueying Wang, Shaoping Huang, Lin Yang, Dan Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pediatrics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1509660/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oxcarbazepine as the initial monotherapy of focal epilepsy in adolescents and adults
by: T. N. Pushkar, et al.
Published: (2021-06-01) -
Real-World Efficacy and Tolerability of Switching from Oxcarbazepine to Eslicarbazepine Therapy in Children Aged 6 Years or Older with Focal Epilepsy
by: Sooyoung Lyu, et al.
Published: (2025-07-01) -
Hemophagocytic lymphohistiocytosis associated with oxcarbazepine
by: Serkan Kırık, et al.
Published: (2019-04-01) -
Epileptiform activity index for assessing oxcarbazepin therapy of newly-diagnosed focal epilepsy in adolescents and adults
by: V. A. Karlov, et al.
Published: (2020-11-01) -
Surface-engineered chitosan-coated nanostructured lipid carriers for intranasal delivery of Oxcarbazepine and Vitamin E oil in epilepsy management
by: Farhan Haider, et al.
Published: (2025-07-01)